Solvay SA (SOLB)

Industry Chemicals


This stock can be held in an Investment ISA and an Investment Account
Sell

€36.40

Buy

€36.96

arrow-up€0.59 (+1.62%)

Prices updated at 10 Oct 2024, 16:35 CEST
| Prices minimum 15 mins delay
|
Prices in EUR

Solvay SA operates in four business segments that are Advanced Materials, Advanced Formulations, Performance Chemicals, and Corporate and Business Services. The Advanced Material segment generate maximum revenue for the company.

Income statement

20222023
7,978m6,025m
1,424m1,383m
805m803m
10.0913.33
1,905m2,093m
2,109m1,307m
Sales, General and administrative565m526m
Interest expenses54m133m
Provision for income taxes228m208m
Operating expenses619m580m
Income before taxes1,132m180m
Net income available to common shareholders1,905m2,093m
18.3720.09
Net interest income14m-89m
Advertising and promotion--
Net investment income, net10m2m
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)18.319.85
Free cash flow per share9.607911.0552
Book value/share108.5395100.6305
Debt equity ratio0.2270110.192247

Balance sheet

20222023
Current assets7,010m2,714m
Current liabilities4,885m2,192m
Total capital12,597m1,264m
Total debt2,915m394m
Total equity10,603m1,264m
Total non current liabilities--
Loans1,994m-
Total assets20,661m7,022m
Total liabilities--
Cash and cash equivalents932m584m
Common stock104m105m

Cash flow

20222023
Cash at beginning of period941m932m
Cash dividends paid-417m-424m
1,097m847m
Investments (gains) losses-831m-1,792m
932m584m
Net income--
2,006m1,911m
-909m-1,064m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2024 Morningstar. All rights reserved.